PE91698A1 - Pirroles sustituidos - Google Patents

Pirroles sustituidos

Info

Publication number
PE91698A1
PE91698A1 PE1997000630A PE00063097A PE91698A1 PE 91698 A1 PE91698 A1 PE 91698A1 PE 1997000630 A PE1997000630 A PE 1997000630A PE 00063097 A PE00063097 A PE 00063097A PE 91698 A1 PE91698 A1 PE 91698A1
Authority
PE
Peru
Prior art keywords
alkyl
aryl
aralkyl
compounds
preferred
Prior art date
Application number
PE1997000630A
Other languages
English (en)
Spanish (es)
Inventor
Donna Mary Huryn
Dennis Dalton Keith
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE91698A1 publication Critical patent/PE91698A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PE1997000630A 1996-07-29 1997-07-15 Pirroles sustituidos PE91698A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2207996P 1996-07-29 1996-07-29

Publications (1)

Publication Number Publication Date
PE91698A1 true PE91698A1 (es) 1998-12-24

Family

ID=21807711

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000630A PE91698A1 (es) 1996-07-29 1997-07-15 Pirroles sustituidos

Country Status (23)

Country Link
US (2) US5856517A (enExample)
EP (1) EP0915872B1 (enExample)
JP (1) JP2000516589A (enExample)
KR (1) KR20000029637A (enExample)
CN (2) CN1495182A (enExample)
AR (1) AR008267A1 (enExample)
AT (1) ATE240318T1 (enExample)
AU (1) AU739742B2 (enExample)
BR (1) BR9711605A (enExample)
CA (1) CA2262092A1 (enExample)
CO (1) CO4900055A1 (enExample)
CY (1) CY2483B1 (enExample)
DE (1) DE69722003T2 (enExample)
DK (1) DK0915872T3 (enExample)
ES (1) ES2198001T3 (enExample)
HR (1) HRP970414A2 (enExample)
MA (1) MA24287A1 (enExample)
PE (1) PE91698A1 (enExample)
PT (1) PT915872E (enExample)
SA (1) SA97180473A (enExample)
TR (1) TR199900157T2 (enExample)
WO (1) WO1998004552A1 (enExample)
ZA (1) ZA976492B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2208612C2 (ru) * 1998-03-17 2003-07-20 Ф.Хоффманн-Ля Рош Аг Замещенные бисиндолималеимиды, предназначенные для ингибирования пролиферации клеток
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
WO2001044235A2 (en) * 1999-12-16 2001-06-21 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
EP1242420A2 (en) * 1999-12-16 2002-09-25 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
US6743785B2 (en) * 1999-12-16 2004-06-01 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
TW201041580A (en) 2001-09-27 2010-12-01 Alcon Inc Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
MY142390A (en) * 2002-05-22 2010-11-30 Glaxosmithkline Llc 3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine)
US7012100B1 (en) * 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
WO2006086484A1 (en) 2005-02-09 2006-08-17 Arqule, Inc. Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
MX2009006533A (es) * 2006-12-19 2009-06-26 Novartis Ag Derivados de indolil-maleimida como inhibidores de cinasa.
WO2009002808A2 (en) 2007-06-22 2008-12-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
EP2170870B1 (en) 2007-06-22 2014-03-05 ArQule, Inc. Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
JP5490688B2 (ja) 2007-06-22 2014-05-14 アークル インコーポレイテッド 癌の治療のためのインドリルピロリジン
JP2009035537A (ja) * 2007-07-10 2009-02-19 Nippon Synthetic Chem Ind Co Ltd:The Ｎ−置換アニリン誘導体及び１−置換インドール誘導体の製造方法
FR2927075A1 (fr) * 2008-02-04 2009-08-07 Centre Nat Rech Scient Molecules comprenant un squelette bis-(heteroaryl)maleimide, et leur utilisation dans l'inhibition d'enzymes
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
AU2015217152A1 (en) 2014-02-11 2016-08-11 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
EP3741375A1 (en) 2014-07-17 2020-11-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
CA3067695A1 (en) 2017-06-21 2018-12-27 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
PT93947B (pt) * 1989-05-05 1996-11-29 Goedecke Ag Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
JPH0539289A (ja) * 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
EP0630241A1 (en) * 1992-03-20 1994-12-28 The Wellcome Foundation Limited Indole derivatives with antiviral activity
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Also Published As

Publication number Publication date
US6030994A (en) 2000-02-29
TR199900157T2 (xx) 1999-04-21
ZA976492B (en) 1998-01-29
DE69722003D1 (de) 2003-06-18
CN1226247A (zh) 1999-08-18
SA97180473A (ar) 2005-12-03
AU739742B2 (en) 2001-10-18
CN1495182A (zh) 2004-05-12
JP2000516589A (ja) 2000-12-12
EP0915872A1 (en) 1999-05-19
BR9711605A (pt) 1999-08-24
KR20000029637A (ko) 2000-05-25
CY2483B1 (en) 2005-06-03
HRP970414A2 (en) 1998-06-30
US5856517A (en) 1999-01-05
DE69722003T2 (de) 2004-04-01
EP0915872B1 (en) 2003-05-14
MA24287A1 (fr) 1998-04-01
ES2198001T3 (es) 2004-01-16
CN1151149C (zh) 2004-05-26
CA2262092A1 (en) 1998-02-05
AU3769097A (en) 1998-02-20
WO1998004552A1 (en) 1998-02-05
ATE240318T1 (de) 2003-05-15
AR008267A1 (es) 1999-12-29
PT915872E (pt) 2003-09-30
CO4900055A1 (es) 2000-03-27
DK0915872T3 (da) 2003-09-08

Similar Documents

Publication Publication Date Title
PE91698A1 (es) Pirroles sustituidos
PE91598A1 (es) Pirroles sustituidos
TW334423B (en) Tricyclic 1-aminoethylpyrrole-derivatives
PE20020228A1 (es) Compuestos organicos como inhibidores de 3',5' guanosin monofosfato ciclico fosfodiesterasa
ES8606370A1 (es) Procedimiento para la obtencion de compuestos de hexapiranosa
ES2118250T3 (es) Combinaciones germicidas de substancias activas.
NO164232C (no) Raskt herdende betongsammensetning.
PE20001516A1 (es) Compuestos triciclicos como inhibidores de la farnesil transferasa
AR240941A2 (es) Procedimiento para preparar compuestos de pirazolopirimidinas
NZ515284A (en) Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
ES2057834T3 (es) Compuestos de triazol de utilidad como desactivadores de metales.
PE91498A1 (es) Pirroles sustituidos
PT73338B (en) 3,1-benzoxazin-2-one ihre herstellung und verwendung
AR011912A1 (es) PROCEDIMIENTO PARA LA PREPARACION DE COMPUESTOS DE 5-AMINO-1-ARIL-3-CIANOPIRAZOL, COMPUESTOS INTERMEDIARIOS DE APLICACIoN EN EL MISMO Y PROCESOS PARA PREPARAR DICHOS COMPUESTOS INTERMEDIARIOS
PE20000734A1 (es) Compuestos heterociclicos derivados de furopiridina y su uso terapeutico
PH23898A (en) New phenyl pyrrolidin-2-yl substituted-2-yl substituted 5-ring heterocycles having antipsycotic properties
ES8800166A1 (es) Procedimiento para la obtencion de imidazoles sustituidos
ES8102096A1 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
PH22537A (en) 3-aminocarbonylmethoxy-5-phenylpyrazole compounds and anti-arrythmic compositions containing them
ES8603876A1 (es) Derivados de pirazol-piridina
ES2066187T3 (es) Compuestos de fosforo.
GB1525892A (en) Process for preparing 1-polyhaloalkyl-3,4-dihydro-2-(1h)-quinazolinones
ES2058870T3 (es) Nuevos compuestos triazolicos.
ES2035919T3 (es) Composiciones fungicidas.
IT1223067B (it) Composto fotocromatico ed articoli fotocromatici che lo contengono

Legal Events

Date Code Title Description
FA Abandonment or withdrawal